Subscribe

Subscribe to MEM Magazine

MEM Health

Pharmaceuticals News

Pharmaceuticals

  • All Post
  • Business
  • Consumer
  • Health
  • In-Motion
  • Infrastructure
  • Manufacturing
  • Sustainability
  • Technology
  • Uncategorized
    •   Back
    • Academia / R&D
    • Testing / NDT
    • Automation
    • Data Centres
    • Training
    • Industry 4 & SMART
    •   Back
    • Government & Legislation
    • Awards & Events
    • Accreditation
    • Appointments & Personnel
    • Legal & Finance
    • MEM Blog
    •   Back
    • Software
    • Tooling
    • Composites / Plastics
    • Additive
    • Chemical
    • Sub-Contract
    •   Back
    • Military & Defence
    • Space
    • Rail
    • Aerospace
    • Marine
    • Automotive
    •   Back
    • Civil & Structural Engineering
    • Nuclear
    • Construction Products
    • Oil & Gas
    • Fabrication
    • Mining
    •   Back
    • Health & Safety
    • Consumer Technology
    • Supplies
    • Medical Technology
    • Pharmaceuticals
    • Public Sector
    •   Back
    • Food & Drink
    • Textiles & Clothing
    • Sports & Leisure
    • Furniture & Furnishings
    • Electricals
    • Packaging & Production
    •   Back
    • Waste Management
    • Environmental
    • EV & Fuel Cells
    • Energy Generation
    • Water Management
    • Recycling

April 24, 2020

FUJIFILM Corporation (President: Kenji Sukeno) has announced that it has expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co., Ltd. to significantly increase production of its influenza antiviral drug “Avigan® Tablet” (generic name: favipiravir) for treating patients with COVID-19. To further boost the supply of Avigan, Fujifilm is allocating additional capacity at its FUJIFILM Wako Pure Chemical Co., Ltd. facility in Japan, for production of pharmaceutical…

Featured MEM Health

Subscribe to MEM Newsletters!